Argon beam coagulation as an adjuvant for local control of giant cell tumor

Clinical Orthopaedics and Related Research

Volumn 454, Issue , 2007, Pages 192-197

  Lewis, Valerae O ^a   Wei, Anthony ^a,b   Mendoza, Tito ^a   Primus, Frank ^c   Peabody, Terrance ^c   Simon, Michael A ^c  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b LOYOLA UNIVERSITY CHICAGO   (United States)

^c UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGON;

ADJUVANT THERAPY; ADOLESCENT; ADULT; ARTHRITIS; ARTICLE; CEMENTATION; CLINICAL ARTICLE; CONFIDENCE INTERVAL; CURETTAGE; DISEASE FREE INTERVAL; EVALUATION; FEMALE; FOLLOW UP; GIANT CELL TUMOR; HUMAN; KAPLAN MEIER METHOD; MALE; OUTCOME ASSESSMENT; PERCEPTION; PRIORITY JOURNAL; RADIOGRAPHY; RECURRENCE RISK; RECURRENT DISEASE; SCORING SYSTEM; SHORT FORM 36; SURVIVAL RATE; BONE TUMOR; CANCER STAGING; HOSPITALIZATION; LASER COAGULATION; METHODOLOGY; MIDDLE AGED; OSTEOCLASTOMA; PATHOLOGY; RETROSPECTIVE STUDY; TUMOR RECURRENCE;

ADOLESCENT; ADULT; ARGON; BONE NEOPLASMS; FEMALE; GIANT CELL TUMOR OF BONE; HUMANS; KAPLAN-MEIERS ESTIMATE; LASER COAGULATION; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX;

EID: 33846042111     PISSN: 0009921X     EISSN: 15281132     Source Type: Journal    
DOI: 10.1097/01.blo.0000238784.98606.d4     Document Type: Article

References (39)

1. Aboulafia AJ, Rosenbaum DH, Sicard-Rosenbaum L, Jelinek JS, Malawer MM. Treatment of large subchondral tumors of the knee with cryosurgery and composite reconstruction. Clin Orthop Relat Res. 1994;307:189-199.
2. Beaton D, Richards RR. Assessing the reliability and responsiveness of 5 shoulder questionnaires. J Shoulder Elbow Surg. 1998;7:565-572.
3. Blackley HR, Wunder JS, Davis AM, White LM, Kandel R, Bell RS. Treatment of giant-cell tumors of long bones with curettage and bone-grafting. J Bone Joint Surg Am. 1999;81:811-820.
4. Bristow RE, Montz FJ. Complete surgical cytoreduction of advanced ovarian carcinoma using the argon beam coagulator. Gynecol Oncol. 2001;83:39-48.
5. Bristow RE, Smith Sehdev AE, Kaufman HS, Montz FJ. Ablation of metastatic ovarian carcinoma with the argon beam coagulator: pathologic analysis of tumor destruction. Gynecol Oncol. 2001;83:49-55.
6. Campanacci M. Giant cell tumor. In: Gaggi A, ed. Bone and Soft Tissue Tumors. Wien, Austria: Springer-Verlag; 1990:117-153.
7. Campanacci M, Baldini N, Boriani S, Sudanese A. Giant-cell tumor of bone. J Bone Joint Surg Am. 1987;69:106-114.
8. Cooper AS, Travers B. Surgical Essays. 3rd ed. London, England: Cox and Son; 1818:178-179.
9. Dahlin DC, Cupps RE, Johnson EW. Giant-cell tumor: a study of 195 cases. Cancer. 1970;25:1061-1070.
10. Eckardt JJ, Grogan TJ. Giant cell tumor of bone. Clin Orthop Relat Res. 1986;204:45-58.
11. Enneking WF. Modification of the system for functional evaluation in the surgical management of muscuoloskeetal tumors. In: Ennecking WF, ed. Limb Salvage in Musculoskeletal Oncology. New York, NY: Churchill Livingstone; 1987:626-627.
12. Gartsman GM, Brinker MR, Khan M. Early effectiveness of arthroscopic repair for full-thickness tears of the rotator cuff: an outcome analysis. J Bone Joint Surg Am. 1998;80:33-40.
13. Ghert MA, Rizzo M, Harrelson JM, Scully SP. Giant-cell tumor of the appendicular skeleton. Clin Orthop Relat Res. 2002;400:201-210.
14. Hang YS. Treatment of giant cell tumor of bone by curettage and polymethylmethacrylate cementation. Taiwan I Hsueh Hui Tsa Chih. 1984;83:98-105.
15. Karam AK, Bristow RE, Bienstock J, Montz FJ. Argon beam coagulation facilitates management of placenta percreta with bladder invasion. Obstet Gynecol. 2003;102:555-556.
16. Leeson MC, Lippitt SB. Thermal aspects of the use of polymethylmethacrylate in large metaphyseal defects in bone: a clinical review and laboratory study. Clin Orthop Relat Res. 1993;295:239-245.
17. Malawer MM, Bickels J, Meller I, Buch RG, Henshaw RM, Kollender Y. Cryosurgery in the treatment of giant cell tumor: a long-term followup study. Clin Orthop Relat Res. 1999;359:176-188.
18. Marcove RC. A 17-year review of cryosurgery in the treatment of bone tumors. Clin Orthop Relat Res. 1982;163:231-234.
19. Marcove RC, Stovell PB, Huvos AG, Bullough PG. The use of cryosurgery in the treatment of low and medium grade chondrosarcoma: a preliminary report. Clin Orthop Relat Res. 1977;122:147-156.
20. Marcove RC, Weis LD, Vaghaiwalla MR, Pearson R, Huvos AG. Cryosurgery in the treatment of giant cell tumors of bone: a report of 52 consecutive cases. Cancer. 1978;41:957-969.
21. McDonald DJ, Sim FH, McLeod RA, Dahlin DC. Giant-cell tumor of bone. J Bone Joint Surg Am. 1986;68:235-242.
22. Miyazawa T, Nawashiro H, Shima K, Bertalanffy H. Early experiences of haemostasis on brain tumour surgery with Argon Plasma Coagulation (APC). Acta Neurochir (Wien). 2000;142:1247-1251.
23. Mjoberg B, Pettersson H, Rosenqvist R, Rydholm A. Bone cement, thermal injury and the radiolucent zone. Acta Orthop Scand. 1984;55:597-600.
24. Nicholson NC, Ramp WK, Kneisl JS, Kaysinger KK. Hydrogen peroxide inhibits giant cell tumor and osteoblast metabolism in vitro. Clin Orthop Relat Res. 1998;347:250-260.
25. Pals SD, Wilkins RM. Giant cell tumor of bone treated by curettage, cementation, and bone grafting. Orthopedics. 1992;15:703-708.
26. Persson BW, Wouters HW. Curettage and acrylic cementation in surgery of giant cell tumors of bone. Clin Orthop Relat Res. 1976;120:125-133.
27. Quint U, Muller RT, Muller G. Characteristics of phenol: instillation in intralesional tumor excision of chondroblastoma, osteoclastoma and enchondroma. Arch Orthop Trauma Surg. 1998;117:43-46.
28. Quint U, Vanhofer U, Harstrick A, Muller RT. Cytotoxicity of phenol to musculoskeletal tumours. J Bone Joint Surg Br. 1996;78:984-985.
29. Remedios D, Saifuddin A, Pringle J. Radiological and clinical recurrence of giant-cell tumour of bone after the use of cement. J Bone Joint Surg Br. 1997;79:26-30.
30. Rock M. Adjuvant management of benign tumors; basic concepts of phenol and cement use. Chir Organi Mov. 1990;75(1 suppl):195-197.
31. Saiz P, Virkus W, Piasecki P, Templeton A, Shott S, Gitelis S. Results of giant cell tumor of bone treated with intralesional excision. Clin Orthop Relat Res. 2004;424:221-226.
32. Sung HW, Kuo DP, Shu WP, Chai YB, Liu CC, Li SM. Giant-cell tumor of bone: analysis of two hundred and eight cases in Chinese patients. J Bone Joint Surg Am. 1982;64:755-761.
33. Trieb K, Bitzan P, Lang S, Dominkus M, Kotz R. Recurrence of curetted and bone-grafted giant-cell tumours with and without adjuvant phenol therapy. Eur J Surg Oncol. 2001;27:200-202.
34. Turcotte RE, Wunder JS, Isler MH, Bell RS, Schachar N, Masri BA, Moreau G, Davis AM. Giant cell tumor of long bone: a Canadian Sarcoma Group study. Clin Orthop Relat Res. 2002;397:248-258.
35. Unni KK. Dahlin's Bone Tumors: General Aspects and Data on 11087 Cases. 5th ed. New York, NY: Lippincott-Raven; 1996.
36. Ward WG Sr, Li G 3rd. Customized treatment algorithm for giant cell tumor of bone: report of a series. Clin Orthop Relat Res. 2002;397:259-270.
37. Ware JE. SF-36 Health Survey: Manual and Interpretation Guide. Boston, MA: Nimrod Press; 1993.
38. Ware JE, Kosinski M, Keller SD. SF-36 Physical and Mental Summary Sales: A User's Manual. Boston, MA: The Health Institute, New England Medical Center; 1994.
39. Ware JE, Sherbourne CD. The MOS 36-Item Short Form Health Survey (SF-36), I: Conceptual framework and item selection. Med Care. 1992;30:473-483.